Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
70,926,754
-
Share change
-
+6,037,217
-
Total reported value
-
$6,386,977,111
-
Put/Call ratio
-
77%
-
Price per share
-
$90.05
-
Number of holders
-
319
-
Value change
-
+$536,253,954
-
Number of buys
-
163
-
Number of sells
-
121
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2021
As of 31 Dec 2021 Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) had 319 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 70,926,754 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, SANDS CAPITAL MANAGEMENT, LLC, BlackRock Inc., Avoro Capital Advisors LLC, FMR LLC, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and Casdin Capital, LLC.
This table shows 322 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.